IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker(Brigham and Women's Hospital), Matt Devalaraja, Florian M.M. Baeres(Novo Nordisk (Denmark)), Mads D.M. Engelmann(Novo Nordisk (Denmark)), G. Kees Hovingh(Novo Nordisk (Denmark)), Milana Ivkovic(Novo Nordisk (Denmark)), Larry Lo, Douglas Kling, Pablo E. Pérgola(Renal Associates P. A.), Dominic S. Raj(George Washington University), Peter Libby(Harvard University), Michael Davidson
Cited by 652
Abstract
Related Papers
No related papers found
Powered by citation graph analysis